Panbela Therapeutics EV/EBIT
¿Qué es el EV/EBIT de Panbela Therapeutics?
El EV/EBIT de Panbela Therapeutics Inc. es N/A
¿Cuál es la definición de EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT de compañías en Sector Health Care en NASDAQ en comparadas con Panbela Therapeutics
¿Qué hace Panbela Therapeutics?
Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company, together with its subsidiaries, focuses on developing disruptive therapeutics for the treatment of patients with cancer. The company focuses on diseases of the pancreas, including pancreatitis and pancreatic cancer, as well as neoadjuvant pancreatic cancer, colorectal cancer, ovarian cancer, and other agents in other cancer indications. Its lead product candidate is SBP-101, which is in Phase Ia/Ib clinical trial for the treatment of patients with metastatic pancreatic ductal adenocarcinoma. The company was formerly known as Sun BioPharma, Inc. and changed its name to Panbela Therapeutics, Inc. in December 2020. Panbela Therapeutics, Inc. was incorporated in 2011 and is based in Waconia, Minnesota.
Empresas con ev/ebit similar a Panbela Therapeutics
- Radha Madhav tiene EV/EBIT de N/A
- Acasti Pharma Inc tiene EV/EBIT de N/A
- Akers Biosciences Inc tiene EV/EBIT de N/A
- Agios Pharmaceuticals Inc tiene EV/EBIT de N/A
- Generation Bio Co tiene EV/EBIT de N/A
- Purple Biotech tiene EV/EBIT de N/A
- Panbela Therapeutics tiene EV/EBIT de N/A
- Continental Materials tiene EV/EBIT de N/A
- GlycoMimetics Inc tiene EV/EBIT de N/A
- Veritas Pharma tiene EV/EBIT de N/A
- Impac Mortgage tiene EV/EBIT de N/A
- Canterra Minerals tiene EV/EBIT de N/A
- Kinnate Biopharma tiene EV/EBIT de N/A